Literature DB >> 15717689

Incidence of diffuse large B-cell lymphoma of germinal center B-cell origin in whole diffuse large B-cell lymphoma: tissue fluorescence in situ hybridization using t(14;18) compared with immunohistochemistry.

Yuko Hirose1, Yasufumi Masaki, Hiromi Karasawa, Kumiko Shimoyama, Toshihiro Fukushima, Hiroshi Kawabata, Noriyoshi Ogawa, Yuji Wano, Mamoru Ozaki.   

Abstract

Diffuse large B-cell lymphoma (DLBCL) can be divided into prognostically important categories such as germinal center B (GCB)-like and non-GCB-like groups. The t(14;18)(q32;q21) translocation defines a unique subset of DLBCL cases with a GCB gene expression profile. Two-color fluorescence in situ hybridization (FISH) analysis was applied to detect t(14;18) (q32;q21) in the nuclei of paraffin-embedded tissue sections from 61 patients with de novo DLBCL. Nine (15%) of 61 cases had a positive pattern. Fifty-seven cases were subclassified in an immunohistochemical study with anti-CD10, anti-bcl-6, and anti-MUM1 antibodies. In this classification, 21 cases (37%) were placed in the GCB group, and 36 (63%) were placed in the non-GCB group. There was a discrepancy between t(14;18) occurrence and bcl-2 protein expression. Bcl-2 protein expression was positive in 40 (67%) of 60 cases. The expression of bcl-2 protein in the GCB and non-GCB groups was not significantly different: 15 (71%) of 21 cases in the GCB group and 24 (67%) of 36 cases in the non-GCB group tested positive. We found no difference between the FISH-positive and FISH-negative groups in overall survival time (P = .6019, log-rank test). The overall survival rates of GCB and non-GCB groups did not differ significantly by immunohistochemical classification (P = .5399, log-rank test). Overall survival was significantly longer in the group with a low International Prognostic Index (IPI) score than in the group with a high IPI score (P = .0002, log-rank test). Our results suggest that immunohistochemical study and cytogenetic study with t(14;18) FISH cannot predict the clinical outcomes of DLBCL patients. A study with a larger number of patients may show a difference in clinical outcomes between FISH-positive and FISH-negative groups and between GCB and non-GCB groups.

Entities:  

Mesh:

Year:  2005        PMID: 15717689     DOI: 10.1532/ijh97.04102

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  26 in total

1.  Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.

Authors:  Margaret A Shipp; Ken N Ross; Pablo Tamayo; Andrew P Weng; Jeffery L Kutok; Ricardo C T Aguiar; Michelle Gaasenbeek; Michael Angelo; Michael Reich; Geraldine S Pinkus; Tane S Ray; Margaret A Koval; Kim W Last; Andrew Norton; T Andrew Lister; Jill Mesirov; Donna S Neuberg; Eric S Lander; Jon C Aster; Todd R Golub
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

Review 2.  Molecular basis of lymphomagenesis.

Authors:  I Magrath
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

3.  Detection of t(14;18) in follicular lymphoma by dual-color fluorescence in situ hybridization on paraffin-embedded tissue sections.

Authors:  Yosuke Matsumoto; Kenichi Nomura; Sawako Matsumoto; Kyoji Ueda; Mitsushige Nakao; Kazuhiro Nishida; Hideaki Sakabe; Shohei Yokota; Shigeo Horiike; Hirokazu Nakamine; Shigeo Nakamura; Masafumi Taniwaki
Journal:  Cancer Genet Cytogenet       Date:  2004-04-01

4.  FISH detection of chromosome 14q32/IgH translocations: evaluation in follicular lymphoma.

Authors:  K A Rack; F Salomon-Nguyen; I Radford-Weiss; M O Gil; C Schmitt; C Belanger; S Nusbaum; M Vekemans; F Valensi; E A Macintyre
Journal:  Br J Haematol       Date:  1998-11       Impact factor: 6.998

5.  bcl-2 rearrangements in de novo diffuse large cell lymphoma. Association with distinctive clinical features.

Authors:  J O Jacobson; B M Wilkes; D J Kwaiatkowski; L J Medeiros; A C Aisenberg; N L Harris
Journal:  Cancer       Date:  1993-07-01       Impact factor: 6.860

Review 6.  Recurring chromosomal abnormalities in non-Hodgkin's lymphoma: biologic and clinical significance.

Authors:  R S Chaganti; G Nanjangud; H Schmidt; J Teruya-Feldstein
Journal:  Semin Hematol       Date:  2000-10       Impact factor: 3.851

7.  Very late relapse in diffuse large B-cell lymphoma represents clonally related disease and is marked by germinal center cell features.

Authors:  Daphne de Jong; Annuska M Glas; Lucie Boerrigter; Marie-Christine Hermus; Otilia Dalesio; Els Willemse; Petra M Nederlof; Marie José Kersten
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

8.  Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

Authors:  Nicolas Mounier; Josette Briere; Christian Gisselbrecht; Jean-Francois Emile; Pierre Lederlin; Catherine Sebban; Francoise Berger; Andre Bosly; Pierre Morel; Herve Tilly; Reda Bouabdallah; Felix Reyes; Philippe Gaulard; Bertrand Coiffier
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

9.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

10.  A predictive model for aggressive non-Hodgkin's lymphoma.

Authors: 
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

View more
  3 in total

1.  The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma: a propensity score matching analysis.

Authors:  Hisakazu Nishimori; Keitaro Matsuo; Yoshinobu Maeda; Yuichiro Nawa; Kazutaka Sunami; Kazuto Togitani; Hidetaka Takimoto; Yasushi Hiramatsu; Toru Kiguchi; Tomofumi Yano; Hiromichi Yamane; Takayuki Tabayashi; Makoto Takeuchi; Masanori Makita; Nobuo Sezaki; Yoshiko Yamasuji; Haruko Sugiyama; Takahiro Tabuchi; Itaru Kataoka; Nobuharu Fujii; Fumihiko Ishimaru; Katsuji Shinagawa; Kazuma Ikeda; Masamichi Hara; Tadashi Yoshino; Mitsune Tanimoto
Journal:  Int J Hematol       Date:  2009-03-27       Impact factor: 2.490

2.  Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.

Authors:  Ana Borovecki; Petra Korać; Marin Nola; Davor Ivanković; Branimir Jaksić; Mara Dominis
Journal:  Croat Med J       Date:  2008-10       Impact factor: 1.351

3.  Clinical Impact of t(14;18) in Diffuse Large B-cell Lymphoma.

Authors:  Hong-Wei Zhang; Niu-Liang Cheng; Zhen-Wen Chen; Jin-Fen Wang; Su-Hong Li; Wei Bai
Journal:  Chin J Cancer Res       Date:  2011-06       Impact factor: 5.087

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.